Safety and Immunogenicity of Trivalent Oral Polio Vaccine in Vaccinated Children and Vaccine-Naïve Infants: A Phase 4 Study

In the context of polio eradication, novel oral polio vaccines for type 2 (nOPV2) were developed, and types 1 and 3 polioviruses are being developed. We aimed to generate trivalent oral poliovirus vaccine (tOPV) safety and immunogenicity data as a reference for comparing with novel OPV formulations....

Full description

Bibliographic Details
Main Authors: Luis Rivera Mejía, Lourdes Peña Mendez, Ricardo W. Rüttimann, Chris Gast, Ananda Sankar Bandyopadhyay
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/12/9/953